Extended Longevity

Extended Longevity

Early Stage

Phytotherapeutic Formulation Protocol

Phytotherapeutic Formulation Protocol

Overview

Raised this Round: Raised: $60,717

Total Commitments ($USD)

Platform

Wefunder

Start Date

10/02/2022

Close Date

12/23/2022

Min. Goal
$50,000
Max. Goal
$107,000
Min. Investment

$100

Security Type

Equity - Preferred

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5.00

Pre-Money Valuation

$45,000,000

Year Founded

2019

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

High

Capital Intensity

Low

Location

Kula, Hawaii

Business Type

Growth

Extended Longevity, with a valuation of $45 million, is raising funds on Wefunder. The company has developed the technology to control the internal biological factors and target them to delay aging. The Extended Longevity technology focuses on decelerating the biomarkers of aging and has developed several products to reverse aging, extend life, and optimize health. The products are already in production at the company’s facilities in Maui, Hawaii, and currently selling. Steven M. Schorr founded Extended Longevity in October 2019. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $107,000. The campaign proceeds will be used for the expansion of the Phytotherapeutic extraction, facilities, and increased inventory, marketing, research and development, and general corporate purposes.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$31,073

$8,513

COGS

$2,410

$693

Tax

$0

$0

 

 

Net Income

$-65,702

$-59,867

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$5,025

$3,245

Accounts Receivable

$7,269

$2,791

Total Assets

$41,128

$24,849

Short-Term Debt

$172,497

$95,816

Long-Term Debt

$5,300

$0

Total Liabilities

$177,797

$95,816

Financials as of: 10/02/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Extended Longevity on Wefunder 2022
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $45,000,000
Price per Share: $5.00

Follow company

Follow Extended Longevity on Wefunder 2022

Buy Extended Longevity's Deal Report

Warning: according to the close date for this deal, Extended Longevity may no longer be accepting investments.

Extended Longevity Deal Report

Get KingsCrowd’s comprehensive report on Extended Longevity including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Extended Longevity is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Extended Longevity deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge